Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells

The small endogenous signaling molecule nitric oxide (NO) has been linked with chronic inflammation and cancer. The effects of NO are both concentration and temporally dependent; under some conditions, NO protects against damage caused by reactive oxygen species and activates P53 signaling. During chronic inflammation, NO causes DNA damage and inhibits repair proteins. To extend our understanding of the roles of NO during carcinogenesis, we investigated the possible effects of chronic NO exposure on MCF10A breast epithelial cells, as defined by changes in cellular morphology, chromosome/genomic stability, RNA, and protein expression, and altered cell phenotypes. Human MCF10A cells were maintained in varying doses of the NO donor DETANO for three weeks. Distinct patterns of genomic modifications in TP53 and KRAS target genes were detected in NO-treated cells when compared to background mutations. In addition, quantitative real-time PCR demonstrated an increase in the expression of cancer stem cell (CSC) marker CD44 after prolonged exposure to 300 mu M DETANO. While similar changes in cell morphology were found in cells exposed to 300-500 mu M DETANO, cells cultured in 100 mu M DETANO exhibited enhanced motility. In addition, 100 mu M NO-treated cells proliferated in serum-free media and selected clonal populations and pooled cells formed colonies in soft agar that were clustered and disorganized. These findings show that chronic exposure to NO generates altered breast epithelial cell phenotypes with malignant characteristics.

Automated summary

The small signaling molecule nitric oxide (NO) is associated with chronic inflammation and cancer. NO can have both protective and damaging effects on cells depending on its concentration and exposure time. In this study, chronic exposure to NO was found to cause altered phenotypes in breast epithelial cells, including changes in cellular morphology, genomic stability, and RNA and protein expression. These altered phenotypes were associated with malignant characteristics, such as increased expression of cancer stem cell marker CD44 and enhanced motility.